After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
F0101B). Quadrant markers were set based on control antibody staining (MAB002). Staining was performed using our Staining Membrane-associated Proteins protocol." class="big_lightbox" target="_blank">
205-IL) stimulates proliferation in the TF-1 human erythroleukemic cell line in a dose-dependent manner (orange line). Proliferation elicited by Recombinant Human IL-5 (0.5 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IL-5 Ra/CD125 Monoclonal Antibody (MAB2531). The ND50 is typically 0.05-0.5 µg/mL." class="big_lightbox" target="_blank">
Species: Hu Applications: Flow, B/N Host: Mouse Monoclonal
405-ML) is immobilized at 4.0 μg/mL (100 μL/well), Recombinant Mouse IL‑5R alpha /CD125 His-tag Protein (Catalog # 11367-5R) binds with an ED50 of 0.250-2.50 µg/mL" class="big_lightbox" target="_blank">
The protein encoded by the IL5RA gene is an interleukin 5 specific subunit of a heterodimeric cytokine receptor. The receptor is comprised of a ligand specific alpha subunit and a signal transducing beta subunit shared by the receptors for interleukin 3 (IL3), colony stimulating factor 2 (CSF2/GM-CSF), and interleukin 5 (IL5). The binding of this protein to IL5 depends on the beta subunit. The beta subunit is activated by the ligand binding, and is required for the biological activities of IL5. This protein has been found to interact with syndecan binding protein (syntenin), which is required for IL5 mediated activation of the transcription factor SOX4. Six alternatively spliced transcript variants encoding three distinct isoforms have been reported. (provided by RefSeq)